Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Ankita Bhagwani

PhD student
Ankita Bhagwani
Ankita Bhagwani

Developing nuclear nanobody-based theranostics for high-risk pediatric sarcomas

I graduated from the National Institute of Pharmaceutical Education and Research, Ahmedabad, India with a master’s degree in Pharmacology and Toxicology, with Neuroscience as a major. I started my PhD journey within the Princess Máxima Center in February 2023.

Molecular imaging and targeted immunotherapy using biologicals, has improved the outcome in many adult cancers. However it is rarely applied in pediatric oncology. Under the supervision of with Dr. Claudia Janda, Prof. Dr. Max van Noesel and Dr. Alex Poot, I aim to develop nanobody-based radiotracers for PET imaging and radioimmunotherapy targeting several biomarkers overexpressed in various pediatric sarcomas and solid tumors. My research mainly focuses on developing nanobodies, radiolabelling them, and determining their in vitro and in vivo binding and efficacy for their clinical potential.

  • Spinal Cord Injury Provoked Neuropathic Pain and Spasticity, and Their GABAergic Connection

    • sep. 2022
    • Ankita, Bhagwani, et al
    • Neurospine
  • The Provenance, Providence, and Position of Endothelial Cells in Injured Spinal Cord Vascular Pathology

    • aug. 2022
    • Manjeet , Chopra, et al
    • Cellular and Molecular Neurobiology
View all publications